Natco Pharma Ltd.

NATCOPHARM

₹1334.65

0.82% (10.85)

Market Cap

₹23,865 Cr.

P/E

17.19

About

Natco Pharma Limited is a vertically integrated pharmaceutical company with a focus on research and development. It specializes in developing, manufacturing, and marketing finished dosage formulations… Read more

Natco Pharma Limited is a vertically integrated pharmaceutical company with a focus on researc… Read more

Low

724

52W Range

High

1349

Quick View

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Company Timeline

Subscribe now for more updates

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE

Latest

14.68%

3yr Average

9.79%

5yr Average

12.01%

Net Profit Margin

Latest

26.42%

3yr Average

18.88%

5yr Average

22.3%

ROCE

Latest

17.62%

3yr Average

12.17%

5yr Average

15.05%

Debt to Equity

Latest

0.03

3yr Average

0.06

5yr Average

0.08

Market Share

0.07 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.74 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

16.71 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

0.11 %

(as of Nov 21)

Historic

Blood Related - Market Share

0.56 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

30 %

(as of Mar 19)

Source/Historic

Copaxone - Market Share

0 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

0.01 %

(as of Jul 21)

Historic

Neurological - Market Share

0.38 %

(as of Nov 21)

Historic

Pain - Market Share

0.47 %

(as of Jul 22)

Historic

Pharmaceutical Sector - Market Share

0.30 %

(as of May 21)

Historic

Respiratory - Market Share

34.62 %

(as of May 19)

Historic

Urology - Market Share

Revenue mix

Product Wise Break-Up

Segment Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Formulation

Location Wise Break-Up

Therapeutic Area Break-Up - Formulation

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

US DMF Filings (.)
Source
Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

Afinitor

Aubagio

Imbruvica

Kyprolis

Nexavar

Pomalyst

Revlimid

Sovaldi

Tarceva

Tykerb

Zytiga

Suppliers

Laurus Labs Ltd.
Shaily Engineering Plastics Ltd.
Take Solutions Ltd.

FAQs on Natco Pharma Ltd. Business

What does Natco Pharma do?

Natco Pharma Limited is a vertically integrated pharmaceutical company that focuses on developing, manufacturing, and marketing pharmaceutical products, along with offering contract manufacturing services and crop health sciences division.

Who are the competitors of Natco Pharma?

Natco Pharma major competitors are Alembic Pharma, Pfizer, JB Chem & Pharma, Ajanta Pharma, Astrazeneca Pharma I, Ipca Laboratories, Sanofi India.
Market Cap of Natco Pharma is ₹23,865 Crs.
While the median market cap of its peers are ₹23,973 Crs.

Is Natco Pharma financially stable compared to its peers?

Natco Pharma seems to be less financially stable compared to its peers.
Altman Z score of Natco Pharma is 20.79 and is ranked 4 out of its 8 competitors.

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Jun			Mar Jun Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec